Skip to main content

7 Result(s)

within Article Remove this filter Hajime Senjo Remove this filter English Remove this filter

and

  1. No Access

    Article

    Unusual computed tomography findings of acute eosinophilic pneumonia after cord blood transplantation

    Hajime Senjo, Daigo Hashimoto in International Journal of Hematology (2019)

  2. Article

    Open Access

    A novel nutritional index “simplified CONUT” and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia

    Elderly patients aged 65 or older with acute myeloid leukemia (AML) have poor prognosis. The risk stratification based on genetic alteration has been proposed in national comprehensive cancer network (NCCN) gu...

    Hajime Senjo, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama… in Scientific Reports (2020)

    Download PDF (848 KB) View Article

  3. No Access

    Article

    Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation

    Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a potentially curative therapy for FLT3 internal tandem duplication mutant (FLT3-ITD+) acute myeloid leukemia, but relapse rate is high. A recent s...

    Zixuan Zhang, Yuta Hasegawa, Daigo Hashimoto, Hajime Senjo… in Bone Marrow Transplantation (2022)

  4. Article

    Open Access

    High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia

    Acute myeloid leukemia (AML) patients older than 65 years have a poor prognosis. Recently, CAR (C-reactive-protein/albumin ratio) has been actively reported as a prognostic index reflecting the nutritional and...

    Hajime Senjo, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama… in Scientific Reports (2022)

    Download PDF (1273 KB) View Article

  5. No Access

    Article

    Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes

    Azacitidine (AZA) improves overall survival (OS) in patients with high-risk myelodysplastic syndromes (MDS). However, predictive factors for response to AZA remain largely unknown. To elucidate whether dynamic...

    Shinpei Harada, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama… in Annals of Hematology (2022)

  6. Article

    Open Access

    Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms

    Patients with lymphoid malignancies have impaired humoral immunity caused by the disease itself and its treatment, placing them at risk for severe coronavirus disease-19 (COVID-19) and reduced response to vacc...

    Mirei Kobayashi, Akio Mori, Masahiro Onozawa, Shihori Tsukamoto… in Annals of Hematology (2023)

    Download PDF (780 KB) View Article

  7. No Access

    Article

    Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan

    Tisagenlecleucel, an autologous CD19-directed T-cell immunotherapy, can induce a durable response in adult patients with relapsed/refractory (r/r) B-cell lymphoma.

    Hideki Goto, Toshio Kitawaki, Nobuharu Fujii… in International Journal of Clinical Oncology (2023)